R. M. Pitkin

Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer’s disease patient brain samples

J. Trojanowski, V. Lee, K. Miller, 2019, Acta Neuropathologica.

Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins

Eric A. Johnson, R. Berntsson, W. Tepp, 2012, Journal of Cell Science.

Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.

J. Trojanowski, K. Luk, Bin Zhang, 2016, Cell reports.

Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies

John L. Robinson, J. Trojanowski, K. Luk, 2018, Nature.

Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease

John L. Robinson, J. Trojanowski, M. Grossman, 2017, Neuropathology and applied neurobiology.

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

J. Trojanowski, V. Lee, K. Luk, 2019, Neurobiology of Disease.